Insider Sentiment Summary: Drugs
Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 13 Weeks

23-Feb-24 - 23-May-24
Buy Ratio:32%

Down
# Net Buyers:8
# Net Sellers:17

Previous 13 Weeks

24-Nov-23 - 22-Feb-24
Buy Ratio:68%
# Net Buyers:23
# Net Sellers:11
View all companies in this industry »
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Zoetis Inc.--$1.64M  
Abbvie Inc.$1.89M$1.47M  
Exelixis, Inc.$1.15M$1.15M  
Pacific Biosciences Of California, Inc.--$942.28K  
Mannkind Corp($301.87K)$500.06K  
New Net Buyers
CompanyNet Buy AmountChange
No data found
Largest Negative Net Change
CompanyNet Buy AmountChange
Larimar Therapeutics, Inc.--($38.00M)  
Biomarin Pharmaceutical Inc($15.12M)($15.12M)  
Kalvista Pharmaceuticals, Inc.--($12.70M)  
Myriad Genetics Inc($7.80M)($7.80M)  
Blueprint Medicines Corp($5.58M)($5.58M)  
New Net Sellers
CompanyNet Buy AmountChange
Biomarin Pharmaceutical Inc($15.12M)($15.12M)  
Insmed Inc($265.63K)($935.44K)  
Galectin Therapeutics Inc($299.06K)($318.33K)  
Amicus Therapeutics, Inc.($95.42K)($195.37K)  
Idexx Laboratories Inc /de($108.16K)($115.45K)